Live Breaking News & Updates on தெளிவு மகிழ்ச்சி

Stay updated with breaking news from தெளிவு மகிழ்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

As he turns 102 years old, New Milford resident recalls a century of memories


As he turns 102 years old, New Milford resident recalls a century of memories
FacebookTwitterEmail
2of5
Clarence Joyce and his wife Mary the day before Clarence s 102nd birthday.Photo courtesy of Nancy SchulzShow MoreShow Less
3of5
4of5
Couple Mary and Clarence Joyce around the year 1945Photo courtesy of Nancy SchulzShow MoreShow Less
5of5
NEW MILFORD When Clarence Joyce was born in a Brookfield farmhouse on March 13, 1919, President Teddy Roosevelt had died in his sleep two months earlier, and the Treaty of Versailles would be signed by the end of June, ending World War I.
Clarence, who turns 102 on Saturday, still remembers the single lightbulb they had, right in the middle of the farmhouse ceiling. ....

New York , United States , New Milford , Clarence Joyce , Nancy Schulz , Henry Abbott Technical High School , Danbury High School , Republic Foil , World War , Great Depression , Teddy Roosevelt , Longview Avenue , World War Ii , World Wari Clarence , Treaty Of Versailles , Co Vid , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது மில்ஃபோர்ட் , தெளிவு மகிழ்ச்சி , நான்சி ஶுல்ஸீ , ஹென்றி அப்போட் தொழில்நுட்ப உயர் பள்ளி , டான்பரி உயர் பள்ளி , குடியரசு படலம் , உலகம் போர் , நன்று மனச்சோர்வு ,

Coronavirus Disease Weekly News 14February 2021


Coronavirus Disease Weekly News 14February 2021
The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.
Please share this article - Go to very top of page, right hand side, for social media buttons.
Summary:
All the important US Covid demographic metrics are falling, and in some cases quite dramatically. This week s new cases were down 19.4% from last week s, and down 62.3% from the second week of January; the 7 day average of new cases is now the lowest since November 4th, but it s also higher than every 7 day period before that date. Illustrative of the decline in new cases was a Thursday headline that n ....

United States , United Kingdom , Czech Republic , San Diego County , San Francisco , Los Angeles County , South Korea , Baylor Hospital , University College , New South Wales , New York , North Carolina , South Africa , Riverside County , University Of Texas , Puerto Rico , Karlovy Vary , New Jersey , Miami Beach , Western University , Sao Francisco , South African , Vladimir Cerny , Petr David Josek , Zweli Mkhize , Brett Kavanaugh ,

Cancer drug shows strong activity against SARS-CoV-2 in lab studies


Cancer drug shows strong activity against SARS-CoV-2 in lab studies
Updated Jan 29, 2021;
Posted Jan 29, 2021
FILE - This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. Viruses are constantly mutating, with coronavirus variants circulating around the globe. (NIAID-RML via AP)AP
Facebook Share
A report released on Jan. 25 by the University of California San Francisco, revealed that scientists at UC San Francisco’s Quantitative Bioscience Institute (QBI) and the Icahn School of Medicine at Mt. Sinai (ISMMS) in New York, have found that “a drug approved by the Australian Regulatory Agency for the treatment of multiple myeloma, has potent antiviral activity against SARS-CoV-2 - the virus that causes COVID-19.” ....

New York , United States , South Africa , University College , New South Wales , South African , Kris White , Nevan Krogan , Clare Jolly , Adolfo Garc , University College London , Uc San Francisco Quantitative Bioscience Institute , Coronavirus Research Consortium , School Of Pharmacy , Pathogens Institute , Australian Regulatory Agency , Global Health , University Of California San Francisco , Icahn School Of Medicine At Mt , California San Francisco , Quantitative Bioscience Institute , Icahn School , Emerging Pathogens Institute , Gladstone Institutes , Research Consortium , Greg Towers ,

Cancer Drug Shows Potent Activity in Lab Against SARS-CoV-2, Including B.1.1.7 Variant


Date Time
Cancer Drug Shows Potent Activity in Lab Against SARS-CoV-2, Including B.1.1.7 Variant
Plitidepsin was 27.5-fold more potent against SARS-CoV-2 than remdesivir, a drug that received FDA emergency use authorization in 2020 for the treatment of COVID-19, according to new research. Image by NIH
Scientists at UC San Francisco’s Quantitative Bioscience Institute (QBI) and the Icahn School of Medicine at Mt. Sinai (ISMMS) in New York have shown that plitidepsin (Aplidin), a drug approved by the Australian Regulatory Agency for the treatment of multiple myeloma, has potent antiviral activity against SARS-CoV-2, the virus that causes COVID-19.
In laboratory experiments reported in Science on Jan. 25, plitidepsin, a compound originally discovered in a Mediterranean sea squirt, was 27.5-fold more potent against SARS-CoV-2 than remdesivir, a drug that received FDA emergency use authorization in 2020 for the treatment of COVID-19. In addition, in two preclinical mo ....

New York , United States , South Africa , University College , New South Wales , South African , Kevan Shokat , Kris White , Nevan Krogan , Clare Jolly , Adolfo Garc , University College London , Uc San Francisco Quantitative Bioscience Institute , National Institute Of Allergy , Coronavirus Research Consortium , Centre For Integrative Biological Signalling Studies , National Institute Of Mental Health , Australian Regulatory Agency , Influenza Research , National Institutes Of Health , School Of Pharmacy , Pathogens Institute , Centers Of Excellence , Defense Advanced Research Projects Agency , Global Health , European Research Council ,